Abstract
Background Diffusion tensor imaging (DTI) is a commonly utilized pre-surgical tractography technique. Despite widespread use, DTI suffers from several critical limitations. These include an inability to replicate crossing fibers and a low angular-resolution, affecting quality of results. More advanced, non-tensor methods have been devised to address DTI’s shortcomings, but they remain clinically underutilized due to lack of awareness, logistical and cost factors.
Objective Nath et al. (2020) described a method of transforming DTI data into non-tensor high-resolution data, suitable for tractography, using a deep learning technique. This study aims to apply this technique to real-life tumor cases.
Methods The deep learning model utilizes a residual convolutional neural network architecture to yield a spherical harmonic representation of the diffusion-weighted MR signal. The model was trained using normal subject data. DTI data from clinical cases were utilized for testing: Subject 1 had a right-sided anaplastic oligodendroglioma. Subject 2 had a right-sided glioblastoma. We conducted deterministic fiber tractography on both the DTI data and the post-processed deep learning algorithm datasets.
Results Generally, all tracts generated using the deep learning algorithm dataset were qualitatively and quantitatively (in terms of tract volume) superior than those created with DTI data. This was true for both test cases.
Conclusions We successfully utilized a deep learning technique to convert standard DTI data into data capable of high-angular resolution tractography. This method dispenses with specialized hardware or dedicated acquisition protocols. It presents an economical and logistically feasible method for increasing access to high definition tractography imaging clinically.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Stanford University.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing Interests: The authors declare no competing interests.
Prior Presentation: None
Funding and Financial Support: None
Abbreviations DTI – diffusion tensor imaging; MT-CSD – Multi-tissue constrained spherical deconvolution; HARDI – High angular resolution diffusion imaging; GQI – Generalized Q-sampling imaging; fODF – Fiber orientation distribution function; SDF – Spin distribution function; ResCNN – Residual convolutional neural network; HCP – Human connectome project; FLAIR – Fluid attenuation inversion recovery; SH – Spherical harmonic; ROI – Region of interest; FA – Fractional anisotropy; QA – quantitative anisotropy; AF – arcuate fasciculus; SLF – superior longitudinal fasciculus; IFOF – Inferior fronto-occipital fasciculus; UF – Uncinate fasciculus; ILF – Inferior longitudinal fasciculus; CST – Corticospinal tract; FAT – Frontal aslant tract
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.